Woo HH - Search Results

1

miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk.

Wang X, Woo HH, Wei M, Gibson S, Miranda M, Rush D, Cragun J, Zheng W, Yao G, Chambers SK. Wang X, et al. Among authors: woo hh. Sci Rep. 2024 Dec 2;14(1):29937. doi: 10.1038/s41598-024-80173-z. Sci Rep. 2024. PMID: 39622842 Free PMC article.

2

Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.

Woo HH, László CF, Greco S, Chambers SK. Woo HH, et al. Mol Cancer. 2012 Aug 21;11:58. doi: 10.1186/1476-4598-11-58. Mol Cancer. 2012. PMID: 22909061 Free PMC article.

3

Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.

Woo HH, Baker T, Laszlo C, Chambers SK. Woo HH, et al. Mol Cell Proteomics. 2013 Jun;12(6):1661-77. doi: 10.1074/mcp.M112.025288. Epub 2013 Mar 7. Mol Cell Proteomics. 2013. PMID: 23471483 Free PMC article.

4

Expression of the cytoplasmic nucleolin for post-transcriptional regulation of macrophage colony-stimulating factor mRNA in ovarian and breast cancer cells.

Woo HH, Lee SC, Gibson SJ, Chambers SK. Woo HH, et al. Biochim Biophys Acta Gene Regul Mech. 2017 Mar;1860(3):337-348. doi: 10.1016/j.bbagrm.2017.01.006. Epub 2017 Jan 25. Biochim Biophys Acta Gene Regul Mech. 2017. PMID: 28131007

5

Human ALKBH3-induced m¹A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells.

Woo HH, Chambers SK. Woo HH, et al. Biochim Biophys Acta Gene Regul Mech. 2019 Jan;1862(1):35-46. doi: 10.1016/j.bbagrm.2018.10.008. Epub 2018 Oct 17. Biochim Biophys Acta Gene Regul Mech. 2019. PMID: 30342176

6

Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer.

Pandey R, Woo HH, Varghese F, Zhou M, Chambers SK. Pandey R, et al. Among authors: woo hh. Transl Oncol. 2019 May;12(5):714-725. doi: 10.1016/j.tranon.2019.01.006. Epub 2019 Mar 9. Transl Oncol. 2019. PMID: 30856556 Free PMC article.

7

The alternative spliced 3'-UTR mediated differential secretion of macrophage colony stimulating factor in breast cancer cells.

Woo HH, Chambers SK. Woo HH, et al. Biochem Biophys Res Commun. 2020 May 14;525(4):1004-1010. doi: 10.1016/j.bbrc.2020.03.007. Epub 2020 Mar 13. Biochem Biophys Res Commun. 2020. PMID: 32178869

8

Regulation of closely juxtaposed proto-oncogene c-fms and HMGXB3 gene expression by mRNA 3' end polymorphism in breast cancer cells.

Woo HH, Chambers SK. Woo HH, et al. RNA. 2021 Sep;27(9):1068-1081. doi: 10.1261/rna.078749.121. Epub 2021 Jun 21. RNA. 2021. PMID: 34155128 Free PMC article.

9

Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.

Woo HH, Yi X, Lamb T, Menzl I, Baker T, Shapiro DJ, Chambers SK. Woo HH, et al. Mol Cell Biol. 2011 Jan;31(1):215-25. doi: 10.1128/MCB.01031-10. Epub 2010 Oct 25. Mol Cell Biol. 2011. PMID: 20974809 Free PMC article.

10

Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA.

Woo HH, Lee SC, Stoffer JB, Rush D, Chambers SK. Woo HH, et al. Transl Oncol. 2019 Jan;12(1):106-115. doi: 10.1016/j.tranon.2018.09.012. Epub 2018 Oct 3. Transl Oncol. 2019. PMID: 30292064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters